Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Filings indexed 2,288 across all filing types
Latest filing 2022-03-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司关于股东股份解质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the release of pledged shares by a shareholder. It details the number of shares released from pledge, the remaining pledged shares, and the shareholder's total holdings. There is no financial report, earnings data, or management discussion. The content focuses on share pledge status, which relates to shareholding and capital structure changes but is specifically about the release of pledged shares. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure about share pledge status and not a capital raising or share issuance event. The document length is short and it is an announcement, not a report or detailed financial statement.
2022-03-24 Chinese
辽宁成大股份有限公司关于公司控股子公司辽宁成大生物股份有限公司建设生物技术产品研发生产基地项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 辽宁成大股份有限公司 regarding an investment project by its controlling subsidiary 辽宁成大生物股份有限公司 to build a biotechnology product R&D and production base. It details the project name, investment amount, construction period, risk factors, necessity, feasibility, and impact on the company. The document is a formal public announcement about a capital investment project, including financial figures and project details, but it is not a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it contains substantive information about the project itself. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes, specifically a major investment project by a subsidiary. The document length is 4187 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2022-03-23 Chinese
辽宁成大股份有限公司关于股东股份质押延期购回的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 辽宁成大股份有限公司 regarding the extension of the pledge repurchase period for certain shareholder shares. It details the number of shares pledged, the shareholders involved, pledge start and extended end dates, and the proportion of shares pledged relative to total share capital. There is no financial statement, earnings data, or management discussion. The document is a specific announcement about share pledge extension, which relates to capital structure but is not a financing update or capital raising event. It is not a report or a regulatory filing about financial results or governance changes. This fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2022-03-23 Chinese
辽宁成大股份有限公司关于股东股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a major shareholder of the company, including details about the number of shares pledged, the pledgee, and the proportion of shares involved. It does not contain financial statements, audit information, or management discussion. It is not an annual or interim report, nor a call transcript or earnings release. The content fits the category of a Major Shareholding Notification, as it informs about changes in significant share ownership levels due to share pledging by a controlling shareholder.
2022-03-15 Chinese
辽宁成大股份有限公司关于股东股份质押延期购回的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the extension of a shareholder's stock pledge redemption period. It details the shareholder's pledged shares, the extension terms, and the impact on the company. There are no financial statements, earnings data, or management discussions. The content focuses on share pledge and financing arrangements by a shareholder, which is a capital structure update. The document length is short (2678 characters) and it is not an announcement of a report publication but a direct disclosure of a financing-related event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-03-14 Chinese
辽宁成大股份有限公司关于股东股份解质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the release of pledged shares by a major shareholder. It details the number of shares released from pledge, the remaining pledged shares, and the shareholder's total holdings. There is no financial statement, audit information, or detailed report content. The document is short (713 characters) and focuses on a specific capital-related event involving share pledges. This fits the category of a capital or financing update rather than a full financial report or other types of filings.
2022-03-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.